Harvard's Gut-Liver Discovery Could Revolutionize Obesity Care

Researchers at Harvard have discovered a surprising link between gut and liver metabolites that could change how we tackle obesity and diabetes. Their study shows that when these metabolites drop, the risk of obesity and insulin resistance skyrockets. One metabolite, mesaconate, even boosts liver insulin signaling, hinting at a bright future for new treatments that tackle the root of these issues.